Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 7 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 6 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 7 days agoPaxton said the claim that the vaccine was 95% effective against infection was misleading. Pfizer...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 6 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 7 days agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Kansas City Star via Yahoo News· 6 days agovaccines became available, Kansans had to decide whether to get the vaccine and which one to take,...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 5 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine, becoming the second ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 6 days agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID-19 vaccine ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoAt the midpoints, earnings would climb more than 22% as sales rise almost 3%. Pfizer Stock And...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 6 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...